An outlook on suicide enzyme inhibition and drug design
| Autor: | Ali Akbar Moosavi-Movahedi, Mina Hajizadeh, Nader Sheibani, Zainab Moosavi-Movahedi |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Drug
chemistry.chemical_classification biology Chemistry media_common.quotation_subject Artificial enzymes Substrate (chemistry) Active site Irreversible inhibition General Chemistry Review Beneficial drug design Enzymes Industrial enzymes Coronavirus Enzyme inhibition Enzyme Biochemistry Suicide inhibition biology.protein Suicide inhibitors Therapeutic potential media_common Peroxidase |
| Zdroj: | Journal of the Iranian Chemical Society |
| ISSN: | 1735-2428 1735-207X |
| Popis: | Graphic abstract There have been recent renewed interests in the importance of suicide enzyme inhibition. The principal objective of this review is to investigate all types of suicide inhibitions for natural enzymes, artificial biocatalysts as well as therapeutic potential of enzyme suicide inhibition. It is discussed the suicide inhibition beneficial in drug design and treatments and non-beneficial achievements for some industrial enzymes such as HRP peroxidase enzyme. The design of biomimetic artificial enzymes explained to prevent inhibition by protecting the active site via environmental conditions. Suicide enzyme inhibition development can be the key mechanism against sever diseases such as SARS. In this report, suicide enzyme inactivation classes are classified based on target enzyme groups via their substrates. Suicide substrate deceives enzyme by its shape similarity to normal substrate and after interaction with enzyme, its suicidal functional group appears (e.g., Trojan horse). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink